Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

Clinical trial NCT07605845 · RECRUITING

Trial details

NCT number: NCT07605845
Sponsor: Gliknik Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2026-04-14
Primary completion: 2027-12-06
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.